Skip to main content
    I

    INVO Fertility, Inc. (IVF)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $0.59
    +0.00 (+0.17%)

    Market Cap: $2.71M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    36%(5/14)
    Avg Surprise
    -672.96%
    Streak
    2 Q

    Upcoming Estimates

    Period ending Sep 30, 2026
    EPS Consensus$-5.20
    Range$-5.20 - $-5.20
    1 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago$0.00n/a
    30d ago$0.00n/a
    7d ago$0.00n/a
    Current$-5.20
    Revenue Consensus
    $3M
    Range$3M - $3M
    1 analysts
    Period ending Dec 31, 2026
    EPS Consensus$-2.40
    Range$-2.40 - $-2.40
    1 analysts
    Revenue Consensus
    $3M
    Range$3M - $3M
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-2.40---
    Sep 26EST
    		-$-5.20---
    Jun 26
    Reported Aug 14
    		$0.35N/A+106.25%Beat+104.3%
    Mar 26
    Reported May 6
    		$-3.38N/A+66.20%Beat+99.7%
    Dec 25
    Reported Dec 31
    		$N/A$-22.00N/ABeat-
    Sep 25
    Reported Nov 17
    		$-0.77$0.00N/ABeat+99.9%
    Jun 25
    Reported Aug 14
    		$-8.07$0.00N/ABeat+99.1%
    Mar 25
    Reported May 20
    		$-1084.80$-420.00-158.29%Miss-79.4%
    Dec 24
    Reported Dec 31
    		$-1084.80$-420.00-158.29%Miss-154871.5%
    Sep 24
    Reported Nov 19
    		$-604.26N/AN/ABeat-19647.1%
    Jun 24
    Reported Aug 14
    		$-895.63N/AN/ABeat-389303.0%
    Mar 24
    Reported May 15
    		$-604.70N/AN/ABeat-287850.3%
    Sep 23
    Reported Nov 13
    		$-0.70N/A+68.18%Beat+84.8%
    Jun 23
    Reported Aug 14
    		$-3.06$-3.20+4.38%Beat+33.5%
    Mar 23
    Reported May 15
    		$-0.23$-0.19-21.05%Miss-215.0%
    Sep 22
    Reported Nov 14
    		$-0.21$-0.12-75.00%Miss+95.6%
    Jun 22
    Reported Aug 15
    		$-4.60$-0.24-1816.67%Miss-35.3%
    Mar 22
    Reported May 16
    		$-4.60$-0.25-1740.00%Miss+8.0%
    Dec 21
    Reported Mar 31
    		$0.20$-0.22+192.29%Beat+102.1%
    Sep 21
    Reported Nov 15
    		$-4.80$-0.20-2300.00%Miss+33.3%
    Jun 21
    Reported Aug 16
    		$-3.40$-0.19-1689.47%Miss-1900.0%
    Mar 21
    Reported May 17
    		$-5.00$-0.25-1900.00%Miss-2677.8%
    Dec 20
    Reported Mar 30
    		$-9.50$0.00N/AMiss+91.5%
    Sep 20
    Reported Dec 2
    		$-7.20N/AN/ABeat+93.2%
    Jun 20
    Reported Aug 13
    		$-0.17N/AN/ABeat+99.5%
    Mar 20
    Reported Jun 29
    		$-0.18N/AN/ABeat-1700.0%
    Dec 19
    Reported Mar 30
    		$-111.59N/AN/ABeat+97.6%
    Sep 19
    Reported Nov 14
    		$-105.20N/AN/ABeat-128.3%
    Jun 19
    Reported Aug 14
    		$-35.85N/AN/ABeat-358352.0%
    Mar 19
    Reported Jun 29
    		$-0.01N/AN/ABeat+100.0%
    Dec 18
    Reported Mar 30
    		$-4698.74N/AN/ABeat-258.9%
    Sep 18
    Reported Nov 14
    		$-46.07N/AN/ABeat+95.3%
    Jun 18
    Reported Aug 14
    		$-0.01N/AN/ABeat+100.0%
    Mar 18
    Reported Jun 29
    		$-23.26N/AN/ABeat+98.3%
    Dec 17
    Reported Mar 30
    		$-1309.33N/AN/ABeat+27.7%
    Sep 17
    Reported Sep 30
    		$-970.31N/AN/ABeat-
    Jun 17
    Reported Jun 30
    		$-893.50N/AN/ABeat-
    Mar 17
    Reported Jun 29
    		$-1406.98N/AN/ABeat-
    Dec 16
    Reported Mar 30
    		$-1811.84N/AN/ABeat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCF-0.30xFCF Yield-338.78%
    Profitability
    Profit Margin-92.30%Operating Margin-59.30%
    ROE-72.70%ROIC-36.09%
    Financial Health
    Debt/Equity0.10xInterest Coverage-5.89x
    Current Ratio0.71xQuick Ratio0.67x
    Trading Statistics
    BetaN/AAvg Volume146.71K
    52-Week High$42.4052-Week Low$0.58

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$0.72
    SMA 20$0.84
    SMA 50$0.96
    SMA 200$2.50
    EMA 10$0.71
    EMA 20$0.80
    EMA 50$0.96
    EMA 200$13.78

    MACD

    Line: -0.10Signal: -0.07Hist: -0.02

    ADX

    ADX: 30.9+DI: 12.9-DI: 37.5

    Aroon & PSAR

    Aroon Up44.0
    Aroon Down100.0
    PSAR$0.72

    Bollinger Bands

    Upper Band$1.11
    Lower Band$0.57
    %B Position6449%(Upper)
    Band Width0.05

    RSI (14-Day)

    Oversold
    18.0

    Momentum Oscillators

    Stoch %K7.6
    Stoch %D5.1
    Williams %R-82.4
    ROC (10d)-34.4%
    Momentum-0.31
    CCI (20d)-163.5
    MFI (14d)5.0

    Volatility Measures

    ATR (14d)$0.08(13.3%)
    StdDev (20d)0.13
    Hist Vol65.8%(High)

    Volume Flow

    VWAP$0.57
    OBV950.0M
    AD Line215.4B
    CMF (20d)-0.309

    Volume Metrics

    Avg Vol (20d)149.7K
    Vol Ratio1.2x
    VWMA (20d)$0.84

    Pivot Points

    R3$0.74
    R2$0.70
    R1$0.65
    Pivot Point$0.61
    S1$0.56
    S2$0.52
    S3$0.47

    Advanced Oscillators

    TSI-46.93
    Ultimate Osc29.6
    KST-257.95

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$2.18M$2.02M$1.58M$1.76M$1.86M$1.64M$1.69M$1.43M$1.84M$1.58M$1.38M$974,894
    Cost of Revenue$1.56M$1.29M$1.05M$1.13M$1.09M$1.04M$957,419$988,465$861,648$850,234$886,750$580,968
    Gross Profit$617,100$727,826$536,860$629,345$770,051$592,256$728,547$444,686$974,949$726,052$495,004$393,926
    Operating Expenses$1.91M$2.32M$3.00M$2.26M$2.36M$3.05M$4.70M$1.75M$2.88M$1.67M$2.00M$1.28M
    R&D$0$0$0$0$0$265,663$484,780$171,224$0$4,880$5,907$2,668
    SG&A$1.91M$2.18M$1.81M$2.13M$2.19M$2.55M$3.48M$1.51M$2.65M$1.44M$1.86M$1.26M
    Operating Income$-1,289,650$-1,590,971$-1,412,256$-1,635,484$-1,592,735$-2,462,343$-3,975,807$-1,300,402$-1,902,913$-946,374$-1,508,468$-886,290
    Interest Income$139,514$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$177,227$180,323$627,107$145,803$221,325$311,270$231,824$273,629$369,612$181,295$182,043$352,085
    Income Before Tax$944,894$-5,539,351$1.86M$-2,644,625$-3,209,094$-17,403,586$-3,677,501$-1,601,403$-2,245,170$-1,594,677$-1,971,747$-1,246,554
    Income Tax Expense$56,154$-150,371$0$0$0$0$-54,008$29,259$0$1,836$23,035$1,886
    Net Income$888,740$-5,539,351$2.01M$-2,644,625$-5,284,858$-17,403,586$-3,623,493$-1,630,662$-2,245,170$-1,596,513$-1,994,782$-1,248,440
    EBITDA$-1,144,077$-5,216,330$2.62M$-2,362,081$-2,818,032$-16,857,854$-3,213,867$-1,097,279$-1,645,220$-1,186,419$-1,648,102$-873,969
    EBIT$-1,289,650$-5,359,028$2.49M$-2,498,822$-2,987,769$-17,092,316$-3,445,677$-1,327,774$-1,875,558$-1,413,379$-1,789,700$-894,473
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about IVF

    News

    IVF Forecast — Price Target — Prediction for 2027

    This article provides a forecast for INVO Fertility, Inc. (IVF) stock, detailing its past performance, financial metrics, and future earnings estimates. It covers historical stock prices, recent earnings, revenue...

    TradingView•10/8/26•Neutral

    INVO Fertility announces investor conference: what it means for INVO Fertility stock

    INVO Fertility announced its participation in the Lytham Partners Fall 2026 Investor Conference, highlighting its shift from a device supplier to a broader fertility-care platform. The company's strategy involves both...

    AD HOC NEWS•10/1/26•Neutral

    INVO Fertility, Inc.'s (NASDAQ:IVF) Shift From Loss To Profit

    INVO Fertility, Inc. (NASDAQ:IVF), a healthcare services company focused on fertility, is projected to shift from a significant loss to profitability within the next two years. Analysts anticipate the company...

    Simply Wall Street•10/1/26•Bullish

    INVO Fertility, Inc. (IVF) Stock Price, News, Quote & History

    This Yahoo Finance page provides comprehensive financial data for INVO Fertility, Inc. (IVF), including its current stock price, historical performance, key financial metrics...

    Yahoo! Finance Canada•9/26/26•Neutral

    INVO Fertility to Participate in the Lytham Partners Fall 2026 Investor Conference

    INVO Fertility, Inc. (Nasdaq: IVF) announced its participation in the Lytham Partners Fall 2026 Investor Conference. The company will deliver a webcast presentation on September 29, 2026...

    The Manila Times•9/25/26•Somewhat-Bullish

    IVF Valuation and Fair Value

    P/FCF
    -0.3x
    P/B
    0.1x
    See GNG's fair value

    IVF Profitability: Margins, ROIC and FCF

    Gross margin
    33.3%
    Operating margin
    -59.3%
    Net margin
    -92.3%
    ROIC
    -36.1%
    ROE
    -72.7%
    FCF margin
    -68.9%
    FCF yield
    -338.8%

    IVF Competitors

    CompanyTicker
    HCW Biologics IncHCWB
    VivoSim Labs, Inc.VIVS
    Painreform LtdPRFX
    Nexalin Technology Inc.NXL
    Revelation Biosciences IncREVB
    iSpecimen IncISPC
    Bioatla IncBCAB
    Biomotion Sciences Ordinary SharesSLXN

    Sector: Healthcare

    IVF Bull Case vs Bear Case

    Bull case

    • IVF grew quarterly revenue 16.7% year over year.

    Bear case

    • IVF has a -92.3% net profit margin.

    IVF Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    -11.9%
    EPS estimate (fiscal period ending Sep 30, 2026)
    $-5.20
    Estimate revisions (30 days, fiscal period ending Sep 30, 2026)
    0 up, 0 down

    Frequently Asked Questions About IVF

    Does IVF pay dividends?

    INVO Fertility, Inc. (IVF) does not currently pay a regular dividend.

    What is IVF's market cap?

    INVO Fertility, Inc. (IVF) has a market capitalization of $2.71M with a current stock price of $0.59.

    Related stocks

    Sector: Healthcare

    All stocks starting with I

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In